13D/13G Filings - F-star Therapeutics Inc. (FSTX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-03-17
4:23 pm
Unchanged
2023-03-07 13G F-star Therapeutics, Inc.
FSTX
Beryl Capital Management LLC 0
0.000%
0
(Unchanged)
Filing
History
2023-02-14
4:06 pm
Unchanged
2022-12-31 13G F-star Therapeutics, Inc.
FSTX
Ridgeback Capital Investments L.P. 52,509
0.200%
0
(Unchanged)
Filing
History
2023-02-14
4:02 pm
Sale
2022-12-31 13G F-star Therapeutics, Inc.
FSTX
Ridgeback Capital Investments L.P. 52,509
0.200%
-1,781,851decrease
(-97.14%)
Filing
History
2022-02-14
6:27 pm
Sale
2021-12-31 13G F-star Therapeutics, Inc.
FSTX
Rock Springs Capital Management LP 751,889
3.650%
-302,343decrease
(-28.68%)
Filing
History
2022-02-14
4:45 pm
Sale
2021-12-31 13G F-star Therapeutics, Inc.
FSTX
Point72 Asset Management, L.P. 987,111
4.800%
-112,889decrease
(-10.26%)
Filing
History
2022-02-14
4:19 pm
Sale
2021-12-31 13G F-star Therapeutics, Inc.
FSTX
Boxer Capital LLC 0
0.000%
-1,501,428decrease
(Position Closed)
Filing
History
2022-02-14
4:15 pm
Purchase
2021-12-31 13G F-star Therapeutics, Inc.
FSTX
Ridgeback Capital Investments L.P. 1,834,360
8.900%
1,340,000increase
(+271.06%)
Filing
History
2022-02-11
5:42 pm
Unchanged
2021-12-31 13G F-star Therapeutics, Inc.
FSTX
Atlas Venture Opportunity Fund I L.P. 599,524
2.900%
0
(Unchanged)
Filing
History
2022-02-10
4:50 pm
Sale
2021-12-31 13G F-star Therapeutics, Inc.
FSTX
GLAXOSMITHKLINE PLC 802,627
3.900%
-1,295decrease
(-0.16%)
Filing
History
2022-02-08
5:00 pm
Sale
2021-12-31 13G F-star Therapeutics, Inc.
FSTX
Merck KGaA 75,140
0.100%
-418,570decrease
(-84.78%)
Filing
History
2021-05-26
4:31 pm
Unchanged
2021-05-12 13D F-star Therapeutics, Inc.
FSTX
Cooperatieve AESCAP Venture I U.A. 615,643
3.100%
0
(Unchanged)
Filing
History
2021-05-18
4:32 pm
Purchase
2021-05-11 13G F-star Therapeutics, Inc.
FSTX
Point72 Asset Management, L.P. 1,100,000
5.700%
1,100,000increase
(New Position)
Filing
History
2021-05-17
4:17 pm
Purchase
2021-05-07 13G F-star Therapeutics, Inc.
FSTX
Rock Springs Capital Management LP 1,054,232
5.730%
1,054,232increase
(New Position)
Filing
History
2021-05-17
4:15 pm
Purchase
2021-05-07 13G F-star Therapeutics, Inc.
FSTX
Boxer Capital LLC 1,501,428
8.200%
1,501,428increase
(New Position)
Filing
History
2021-04-09
4:54 pm
Purchase
2021-03-30 13G F-star Therapeutics, Inc.
FSTX
Ridgeback Capital Investments L.P. 494,360
5.400%
86,793increase
(+21.30%)
Filing
History
2021-02-16
4:20 pm
Purchase
2020-12-31 13G F-star Therapeutics, Inc.
FSTX
Ridgeback Capital Investments L.P. 407,567
4.500%
407,567increase
(New Position)
Filing
History
2021-02-12
8:17 pm
Purchase
2020-12-31 13G F-star Therapeutics, Inc.
FSTX
BIOTECHNOLOGY VALUE FUND L P 25,844
1.000%
25,844increase
(New Position)
Filing
History
2021-02-03
5:20 pm
Purchase
2020-11-20 13G F-star Therapeutics, Inc.
FSTX
Atlas Venture Fund VII L P 574,996
6.300%
574,996increase
(New Position)
Filing
History
2021-02-03
5:14 pm
Purchase
2020-11-20 13G F-star Therapeutics, Inc.
FSTX
Atlas Venture Opportunity Fund I L.P. 599,524
6.600%
599,524increase
(New Position)
Filing
History
2021-02-01
4:32 pm
Purchase
2020-12-31 13G F-star Therapeutics, Inc.
FSTX
Merck KGaA 493,710
5.400%
493,710increase
(New Position)
Filing
History
Goto 0, 1, Next